HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Previous close
$0.64
Year range
$0.60 - $1.06
Market cap
29.12M CAD
Avg Volume
10.20K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 731.71K | -16.67% |
Net income | -651.32K | 25.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.97M | 7.06% |
Total assets | 5.06M | 7.78% |
Total liabilities | 308.45K | -11.83% |
Total equity | 4.76M | — |
Shares outstanding | 45.50M | — |
Price to book | 6.40 | — |
Return on assets | -34.03% | — |
Return on capital | -36.23% | — |
Cash Flow
Net change in cash
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -651.32K | 25.17% |
Cash from operations | -551.12K | 19.56% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -553.58K | 18.11% |
Free cash flow | -357.12K | 1.77% |
About
Founded
2018
Headquarters
Website